טוען...
JAK1 selective inhibitors for the treatment of spondyloarthropathies
As our understanding of the pathogenesis of SpA improves, focus has turned to the role janus kinase (JAK)-mediated signal transduction and inhibiting its actions as a therapeutic mechanism. Small molecule inhibitors of JAK exist, with variable selectivity for the different JAK isoforms. Less selecti...
שמור ב:
| הוצא לאור ב: | Rheumatology (Oxford) |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8098108/ https://ncbi.nlm.nih.gov/pubmed/33950224 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/keaa815 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|